Surgery Partners announced a proposed public offering of 6 million shares.
Four details:
1. The company said it plans to use net proceeds from the public offering for general corporate purposes.
2. J.P. Morgan Securities and Jefferies are acting as lead book-running managers. The acting joint book-running managers for the public offering are Barclays Capital, KKR Capital Markets and Macquarie Capital.
3. Surgery Partners reported 2020 revenue of $1.86 billion on Jan. 11 and reaffirmed its EBITDA guidance as being $250 million to $260 million. The company had 116 ASCs and 17 short-stay surgical hospitals in its portfolio at the end of the year.
4. Despite the pandemic, Surgery Partners made 10 acquisitions last year for around $160 million and plans to deploy more than $100 million in capital in 2021.